Save
Share
The Fifth Estate Emerging Fund has wrapped up a fundraising round. Â
Louise Kennerley
Street Talk understands the pairâs Fifth Estate Emerging Fund wrapped up a fundraising round this week, locking in around $48 million from high net worths, family offices and the like.
It is already holding seven pre-IPO investments straight out the gate, including healthcare technology outfit Lumos Diagnostics. This column revealed earlier this week that Lumos had called in Bell Potter and Wilsons for its float, which is expected to see it raise about $60 million and ramp up in the next fortnight.
The investment strategy for the fund will be overseen by Centennial and Bluelake, as well as ex-Regal Funds Management small companies portfolio manager Dane Roberts.
Morgan Stanley equity sales veteran heads to buyside
Save
Share
The invesment team behind Centennial Asset Management/BlueLake Partnersâ freshly launched pre-IPO fund has got one more member.
Morgan Stanleyâs Michael Carmody is on the move.Â
Mayu Kanamori
Carmody has been with Morgan Stanley for the past decade, and prior to that spent almost ten years at Bank of America. It is understood he will join Centennial as an executive director for investments and business development.
His hire takes Centennialâs investment team to three, and Carmody will work closely with founders Matthew Kidman and Gary Joffe.
Centennial has two core funds, its Level 18 long/short equity fund â focused on small caps â and the Centennial Conviction Fund, which invests in a smaller concentration of listed small cap companies.